Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥1,254 JPY
Change Today -22.00 / -1.72%
Volume 106.7K
As of 2:00 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daiken medical co ltd (7775)

This company's debt to total capital ratio, at 13.03%, is in-line with the Healthcare Equipment and Supplies industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Cash Collection is a strong suit as the company is more effective than most in the industry. As of the end of 2014, its uncollected receivables totaled ¥2.5B JPY, which, at the current sales rate provides a Days Receivables Outstanding of 113.75. Last, Daiken Medical Co., Ltd. is among the least efficient in its industry at managing inventories, with 92.77 days of its Cost of Goods Sold tied up in Inventories.
View Balance Sheet In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Mar 31
2011
JPY
Mar 31
2012
JPY
Mar 31
2013
JPY
Mar 31
2014
JPY
4 Year
Trend
Assets    
Cash and Equivalents1,498.01,656.01,911.01,960.0
TOTAL CASH AND SHORT TERM INVESTMENTS1,498.01,656.01,911.01,960.0
Accounts Receivable2,369.02,216.02,282.02,477.0
TOTAL RECEIVABLES2,369.02,216.02,282.02,477.0
Inventory803.01,053.0919.0968.0
Prepaid Expenses24.017.023.026.0
Deferred Tax Assets, Current121.0120.0161.0196.0
Other Current Assets32.057.091.039.0
TOTAL CURRENT ASSETS4,847.05,119.05,387.05,666.0
NET PROPERTY PLANT AND EQUIPMENT2,539.02,396.02,302.02,301.0
Long-Term Investments126.0121.0127.0124.0
Deferred Tax Assets, Long Term261.073.059.048.0
Other Intangibles87.0103.087.093.0
Other Long-Term Assets1.02.02.01.0
TOTAL ASSETS7,861.07,814.07,964.08,233.0
    
LIABILITIES & EQUITY    
Accounts Payable868.0783.0767.0849.0
Accrued Expenses248.0266.0268.0292.0
Short-Term Borrowings167.0456.0167.0258.0
Current Portion of Long-Term Debt/Capital Lease683.0523.0399.0318.0
Current Income Taxes Payable439.0405.0645.0697.0
Other Current Liabilities, Total19.021.028.037.0
TOTAL CURRENT LIABILITIES2,424.02,454.02,274.02,451.0
Long-Term Debt744.0866.0566.0248.0
Pension & Other Post-Retirement Benefits530.082.0----
Other Non-Current Liabilities14.013.056.033.0
TOTAL LIABILITIES3,712.03,415.02,896.02,732.0
Common Stock495.0495.0495.0495.0
Additional Paid in Capital422.0423.0447.0486.0
Retained Earnings3,371.03,613.04,231.04,612.0
Treasury Stock-141.0-135.0-108.0-94.0
Comprehensive Income and Other2.03.03.02.0
TOTAL COMMON EQUITY4,149.04,399.05,068.05,501.0
TOTAL EQUITY4,149.04,399.05,068.05,501.0
TOTAL LIABILITIES AND EQUITY7,861.07,814.07,964.08,233.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
7775:JP ¥1,254.00 JPY -22.00

7775 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 7775.
View Industry Companies
 

Industry Analysis

7775

Industry Average

Valuation 7775 Industry Range
Price/Earnings 38.0x
Price/Sales 4.8x
Price/Book 6.8x
Price/Cash Flow 38.8x
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAIKEN MEDICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.